Side-by-side comparison
Pentadeca Arginate (PDA) vs Capromorelin
Arginate-salt analog of BPC-157 developed for improved injection stability and tissue repair. versus Oral non-peptide ghrelin-receptor agonist; FDA-approved as a veterinary appetite stimulant.
Pentadeca Arginate (PDA)
RecoveryArginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.
Top benefits
- ✓Tendon and ligament healing
- ✓Better stability than BPC-157 acetate
- ✓Anti-inflammatory
Capromorelin
PerformanceOral non-peptide ghrelin-receptor agonist; FDA-approved as a veterinary appetite stimulant.
Top benefits
- ✓Stimulates appetite
- ✓Raises GH/IGF-1
- ✓Oral bioavailability
| Attribute | Pentadeca Arginate (PDA) | Capromorelin |
|---|---|---|
| Category | Recovery | Performance |
| Type | linear | small-molecule |
| Chain length | 15 aa | 1 aa |
| Formula | BPC-157 arginate salt | C28H36N4O4 |
| Common dose | 250-500 mcg | 3 mg/kg (dog) |
| Frequency | 1-2x daily SC | Daily, oral |
| Top benefit | Tendon and ligament healing | Stimulates appetite |
| Top side-effect | Injection-site irritation | Hypersalivation (in dogs/cats) |
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.